TR199701654T1 - 4-Fenilaminotiyazol türevleri. - Google Patents

4-Fenilaminotiyazol türevleri.

Info

Publication number
TR199701654T1
TR199701654T1 TR97/01654T TR9701654T TR199701654T1 TR 199701654 T1 TR199701654 T1 TR 199701654T1 TR 97/01654 T TR97/01654 T TR 97/01654T TR 9701654 T TR9701654 T TR 9701654T TR 199701654 T1 TR199701654 T1 TR 199701654T1
Authority
TR
Turkey
Prior art keywords
revleri
fenilaminotiyazol
stereoisomers
formula
addition salts
Prior art date
Application number
TR97/01654T
Other languages
English (en)
Inventor
Gully Danielle
Roger Pierre
Camille Wermuth Georges
Original Assignee
Sanofi
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sanofi filed Critical Sanofi
Publication of TR199701654T1 publication Critical patent/TR199701654T1/tr

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D417/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/12Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00Drugs for genital or sexual disorders; Contraceptives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00Drugs for disorders of the endocrine system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00Drugs for disorders of the endocrine system
    • A61P5/02Drugs for disorders of the endocrine system of the hypothalamic hormones, e.g. TRH, GnRH, CRH, GRH, somatostatin
    • A61P5/04Drugs for disorders of the endocrine system of the hypothalamic hormones, e.g. TRH, GnRH, CRH, GRH, somatostatin for decreasing, blocking or antagonising the activity of the hypothalamic hormones
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D277/00Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/20Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D277/32Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D277/38Nitrogen atoms
    • C07D277/42Amino or imino radicals substituted by hydrocarbon or substituted hydrocarbon radicals

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Endocrinology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Reproductive Health (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Thiazole And Isothizaole Compounds (AREA)

Abstract

Asagidaki formül (I)'e sahip aminotiyazol türevleri: ve bunlarin stereoizomerleri ve/ya da katilma tuzlari.
TR97/01654T 1995-06-21 1996-06-18 4-Fenilaminotiyazol türevleri. TR199701654T1 (tr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9507437A FR2735777B1 (fr) 1995-06-21 1995-06-21 Derives de 4-phenylaminothiazole, leur procede de preparation et les compositions pharmaceutiques les contenant

Publications (1)

Publication Number Publication Date
TR199701654T1 true TR199701654T1 (tr) 1998-05-21

Family

ID=9480235

Family Applications (1)

Application Number Title Priority Date Filing Date
TR97/01654T TR199701654T1 (tr) 1995-06-21 1996-06-18 4-Fenilaminotiyazol türevleri.

Country Status (22)

Country Link
US (1) US5880135A (tr)
EP (1) EP0833822A1 (tr)
JP (1) JP3067807B2 (tr)
KR (1) KR19990028325A (tr)
AU (1) AU710300B2 (tr)
BR (1) BR9609420A (tr)
CA (1) CA2222266A1 (tr)
CZ (1) CZ410397A3 (tr)
EE (1) EE9700333A (tr)
FR (1) FR2735777B1 (tr)
HU (1) HUP9900056A2 (tr)
IL (1) IL122293A0 (tr)
IS (1) IS4635A (tr)
NO (1) NO975987L (tr)
NZ (1) NZ312157A (tr)
PL (1) PL324202A1 (tr)
RU (1) RU2146253C1 (tr)
SK (1) SK171197A3 (tr)
TR (1) TR199701654T1 (tr)
TW (1) TW416952B (tr)
WO (1) WO1997000868A1 (tr)
ZA (1) ZA965294B (tr)

Families Citing this family (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6313124B1 (en) 1997-07-23 2001-11-06 Dupont Pharmaceuticals Company Tetrazine bicyclic compounds
US6124289A (en) * 1996-07-24 2000-09-26 Dupont Pharmaceuticals Co. Azolo triazines and pyrimidines
US6060478A (en) * 1996-07-24 2000-05-09 Dupont Pharmaceuticals Azolo triazines and pyrimidines
US6191131B1 (en) 1997-07-23 2001-02-20 Dupont Pharmaceuticals Company Azolo triazines and pyrimidines
US7094782B1 (en) 1996-07-24 2006-08-22 Bristol-Myers Squibb Company Azolo triazines and pyrimidines
FR2754258B1 (fr) 1996-10-08 1998-12-31 Sanofi Sa Derives d'aminothiazole, leur procede de preparation et les compositions pharmaceutiques les contenant
US6187777B1 (en) * 1998-02-06 2001-02-13 Amgen Inc. Compounds and methods which modulate feeding behavior and related diseases
KR20010080402A (ko) * 1998-11-12 2001-08-22 추후기재 Crf 수용체 길항제 및 그와 관련된 방법
US6531475B1 (en) * 1998-11-12 2003-03-11 Neurocrine Biosciences, Inc. CRF receptor antagonists and methods relating thereto
JP2002529465A (ja) 1998-11-12 2002-09-10 ニューロクライン バイオサイエンシーズ, インコーポレイテッド Crfレセプターアンタゴニストおよびcrfレセプターアンタゴニストに関する方法
FR2796380B3 (fr) * 1999-07-15 2001-08-17 Sanofi Synthelabo Nouveaux derives d'aminothiazoles, leur preparation et les compositions pharmaceutiques les contenant
FR2819508B1 (fr) * 2001-01-12 2005-01-21 Sod Conseils Rech Applic Derives de 2-arylimino-2, 3-dihydorthiazoles, leurs procedes de preparation et leur utilisation therapeutiques
US6432989B1 (en) * 1999-08-27 2002-08-13 Pfizer Inc Use of CRF antagonists to treat circadian rhythm disorders
CO5271670A1 (es) * 1999-10-29 2003-04-30 Pfizer Prod Inc Antagonistas del factor de liberacion de corticitropina y composiciones relacionadas
AU2001234180A1 (en) * 2000-02-25 2001-09-03 Japan Tobacco Inc. Benzamide derivative and use thereof
EP1149583A3 (en) * 2000-04-13 2001-11-14 Pfizer Products Inc. Combinations of corticotropin releasing factor antagonists and growth hormone secretagogues
DE10045650A1 (de) * 2000-09-15 2002-03-28 Wuerth Adolf Gmbh & Co Kg Kunststoffdübel
US7205320B2 (en) 2001-01-22 2007-04-17 Memory Pharmaceuticals Corp. Phosphodiesterase 4 inhibitors
US7153871B2 (en) * 2001-01-22 2006-12-26 Memory Pharmaceuticals Corporation Phosphodiesterase 4 inhibitors, including aminoindazole and aminobenzofuran analogs
EP1423113A4 (en) * 2001-08-13 2007-04-18 Phenex Pharmaceuticals Ag NR1H4 NUCLEAR RECEPTOR BINDING COMPOUNDS
BR0313000A (pt) * 2002-07-19 2005-07-12 Memory Pharm Corp Compostos, composição farmacêutica e método para efetuar a inibição da enzima pde4, realçar a cognição e/ou tratar a psicose em um paciente
NZ537724A (en) 2002-07-19 2006-10-27 Memory Pharm Corp Phosphodiesterase 4 inhibitors, including N-substituted aniline and diphenylamine analogs
BR0315705A (pt) * 2002-11-19 2005-09-06 Memory Pharm Corp Inibidores de fosfodiesterase-4
US20090048255A1 (en) * 2003-07-21 2009-02-19 Schumacher Richard A Phosphodiesterase 4 inhibitors, including n-substituted aniline and diphenylamine analogs
MY141255A (en) * 2003-12-11 2010-03-31 Memory Pharm Corp Phosphodiesterase 4 inhibitors, including n-substituted diarylamine analogs
KR20080091369A (ko) * 2006-01-18 2008-10-10 암젠 인크 단백질 키나제 b (pkb) 억제제로서 티아졸 화합물
US8252333B2 (en) 2006-01-26 2012-08-28 Jorge Cueto-Garcia Biodegradable, non-toxic biological adhesive for use in abdominal surgery
US20100029689A1 (en) * 2008-07-02 2010-02-04 Memory Pharmaceuticals Corporation Phosphodiesterase 4 inhibitors
WO2015166370A1 (en) 2014-04-28 2015-11-05 Pfizer Inc. Heteroaromatic compounds and their use as dopamine d1 ligands

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2612187B1 (fr) * 1987-03-12 1989-07-21 Sanofi Sa Derives du thiazole actifs sur le systeme cholinergique, leur procede de preparation et compositions pharmaceutiques en contenant
FR2656610B1 (fr) * 1989-12-29 1992-05-07 Sanofi Sa Derives d'amino-2 phenyl-4 thiazole, leur procede de preparation et leur application therapeutique.
FR2692893B1 (fr) * 1992-06-24 1994-09-02 Sanofi Elf Dérivés alkylamino ramifiés du thiazole, leurs procédés de préparation et les compositions pharmaceutiques qui les contiennent.

Also Published As

Publication number Publication date
SK171197A3 (en) 1998-08-05
TW416952B (en) 2001-01-01
JPH10511693A (ja) 1998-11-10
WO1997000868A1 (fr) 1997-01-09
FR2735777A1 (fr) 1996-12-27
NO975987L (no) 1998-02-19
BR9609420A (pt) 1999-05-18
HUP9900056A2 (hu) 1999-05-28
RU2146253C1 (ru) 2000-03-10
CZ410397A3 (cs) 1998-04-15
PL324202A1 (en) 1998-05-11
MX9710378A (es) 1998-07-31
AU710300B2 (en) 1999-09-16
IS4635A (is) 1997-12-16
US5880135A (en) 1999-03-09
FR2735777B1 (fr) 1997-09-12
ZA965294B (en) 1997-12-22
JP3067807B2 (ja) 2000-07-24
KR19990028325A (ko) 1999-04-15
CA2222266A1 (fr) 1997-01-09
NO975987D0 (no) 1997-12-19
IL122293A0 (en) 1998-04-05
EP0833822A1 (fr) 1998-04-08
EE9700333A (et) 1998-06-15
AU6362796A (en) 1997-01-22
NZ312157A (en) 1999-04-29

Similar Documents

Publication Publication Date Title
TR199701654T1 (tr) 4-Fenilaminotiyazol türevleri.
TR199700844T1 (tr) Pirazolil-Benzoil Türevleri.
TW334418B (en) Stilbene derivatives and pharmaceutical compositions
NO932873D0 (no) 9-((substituerte glycyl)amido)-6-dementyl-6-deoksotetrasykliner
ATE196761T1 (de) Inhibitoren retroviraler proteasen
ATE226201T1 (de) Substituierte pyridylpyrazole
ES2138691T3 (es) Procedimiento para la obtencion de derivados de n-acil-5-fluorocitidina.
DK0618190T3 (da) 9-(Substitueret glycyl)amido-6-(substitueret)-5-hydroxy-6-deoxy-tetracycliner
ES2172069T3 (es) Derivado tetrapeptidico.
TR200200579T2 (tr) Amino-tirazolpiridin türevleri.
NO963370D0 (no) Nye mercaptoacetylamido-1,3,4,5-tetrahydro-benzo[cÅazepin-3-on-disulfidderivater som er anvendbare som inhibitorer av enkefalinase og ACE
MX9205726A (es) Derivados de 4'-(n-substituido-n-oxido) estaurosporina.
NO306116B1 (no) Ny benzotiadiazinforbindelse og farmasöytiske sammensetninger
ES2135722T3 (es) 1,5-benzodiacepinas 5-heterociclicas moduladoras de la cck o de la gastrina.
RS50002B (sr) Eletriptan hidrobromid monohidrat
DK0842185T3 (da) Ara-C-derivater
TR199701202T1 (tr) Yeni hidroksimik asit türevleri.
DK1073447T3 (da) N1-modificerede glycopeptider
FI930092A0 (fi) Indanopyrrolidinkarbamater
MA23133A1 (fr) Derives d'acide d'acyloxyhexanoique .
ES2080336T3 (es) Derivados de metilpiperazinoazepina, su preparacion y su utilizacion.
ES2087567T3 (es) Derivados antibioticos de 7'-amino-naftazarina.
TR199701011A2 (tr) 1-karba-(detia)-sefalosforin türevleri.
ATE231838T1 (de) N,n'-diacylthiocystine
SE9501163D0 (sv) Regel till tysta 'dörrar'